Table 4.
Responses on barriers in using EBM (No., %)
| Statement | Family medicine specialist | Family doctor | Total | P-valuea |
|---|---|---|---|---|
| There is not enough evidence relevant for family medicine practice | ||||
| Not a barrier | 78 (54.2) | 49 (38.6) | 127 (54) | 0.844 |
| Significant barrier | 61 (60.4) | 40 (39.6) | 101 (43) | |
| Very significant barrier | 5 (71.4) | 2 (28.6) | 7 (3) | |
| Patients request treatments that have no proven medical efficacy | ||||
| Not a barrier | 53 (68.8) | 24 (31.2) | 77 (32.8) | 0.234 |
| Significant barrier | 64 (56.6) | 49 (43.4) | 113 (48.1) | |
| Very significant barrier | 27 (60) | 18 (40) | 45 (19.1) | |
| I do not have enough skills for finding evidence | ||||
| Not a barrier | 81 (64.3) | 45 (35.7) | 126 (53.4) | 0.185 |
| Significant barrier | 57 (61.3) | 36 (38.7) | 93 (39.4) | |
| Very significant barrier | 7 (41.2) | 10 (58.8) | 17 (7.2) | |
| I do not have enough time for finding evidence | ||||
| Not a barrier | 29 (63) | 17 (37) | 46 (19.7) | 0.036 |
| Significant barrier | 88 (67.2) | 43 (32.8) | 131 (56) | |
| Very significant barrier | 27 (47.4) | 30 (52.6) | 57 (24.4) | |
| I do not have enough skills for critical assessment of evidence | ||||
| Not a barrier | 58 (63) | 34 (37) | 92 (39.5) | 0.112 |
| Significant barrier | 79 (64.2) | 44 (35.8) | 123 (52.8) | |
| Very significant barrier | 7 (38.9) | 11 (61.1) | 18 (7.7) | |
| I do not have enough time for reading and assessment of evidence | ||||
| Not a barrier | 35 (70) | 15 (30) | 50 (21.2) | 0.325 |
| Significant barrier | 82 (60.3) | 54 (39.7) | 136 (57.6) | |
| Very significant barrier | 28 (56) | 22 (44) | 50 (21.2) | |
| I do not have enough skills in presenting results of relevant research to my patients | ||||
| Not a barrier | 69 (63.9) | 39 (36.1) | 108 (46) | 0.722 |
| Significant barrier | 62 (59.6) | 42 (40.4) | 104 (44.3) | |
| Very significant barrier | 13 (56.5) | 10 (43.5) | 23 (9.8) | |
| I do not have enough time to discuss research results with my patients during their scheduled appointment with me | ||||
| Not a barrier | 32 (71.7) | 13 (28.9) | 45 (19.1) | 0.308 |
| Significant barrier | 76 (60.8) | 49 (39.2) | 125 (53.2) | |
| Very significant barrier | 37 (56.9) | 28 (43.1) | 65 (27.7) | |
| The use of EBM will further limit the number of patients that I can examine at my medical office | ||||
| Not a barrier | 66 (66.7) | 33 (33.3) | 99 (42.1) | 0.150 |
| Significant barrier | 66 (60) | 44 (40) | 110 (46.8) | |
| Very significant barrier | 12 (46.2) | 14 (53.8) | 26 (11.1) | |
| Despite the results of relevant studies, patients have unrealistic expectations that influence my choice of treatment | ||||
| Not a barrier | 47 (71.2) | 19 (28.8) | 66 (28.2) | 0.05 |
| Significant barrier | 71 (60.7) | 46 (39.3) | 117 (50) | |
| Very significant barrier | 25 (49) | 26 (51) | 51 (21.8) | |
| I am concerned about the financial aspects of my practice because the access to EBM sources is costly | ||||
| Not a barrier | 64 (79) | 17 (21) | 81 (34.4) | < 0.001 |
| Significant barrier | 52 (56.5) | 40 (43.5) | 92 (39) | |
| Very significant barrier | 29 (46) | 34 (54) | 63 (26.7) | |
aχ2-test